New Approaches to Vaccine Development and Delivery
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccination Optimization".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 258
Special Issue Editor
Interests: nucleic acid vaccine; yeast-based vaccines; application of immunoinformatics in novel vaccine design; development and evaluation of HPV therapeutic; vaccine Zika; viral pathogenesis; Vaccine delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The COVID-19 pandemic created an opportunity for innovation in the development, evaluation, and speed of vaccine development and evaluation. Contemporary strategies such as nucleic acid vaccines, developing vaccines based on whole cells, exploring new vaccine delivery methods, and creating shelf-stable formulas have made it possible to approach prophylactic and therapeutic vaccines in new ways. In this Special Issue, we will examine new advances in the field of vaccines and delivery systems that could help propel the field forward beyond its previous limits.
Dr. Antonio Carlos de Freitas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- formulation
- vaccine delivery
- yeast-based vaccines
- surface display
- yeast shell
- delivery systems
- mRNA vaccines
- DNA vaccines
- subunit vaccine
- adjuvant
- virus-like particles (VLPs)
- quality control
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
